Protocol title: Expanded PrEP Implementation in Communities in NSW (EPIC-NSW)
Registry: ClinicalTrials.gov
Registry #: NCT02870790
Link to registry: See Registry
Protocol title: Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 (MODERN)
Registry: Australian New Zealand Clinical Trials Registry (ANZCTR)
Registry #: NCT01345630
Link to registry: See Registry
Protocol title: Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults
Registry: ClinicalTrials.gov
Registry #: NCT02386098
Link to registry: See Registry
Protocol title: Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Registry: ClinicalTrials.gov
Registry #: NCT01106586
Link to registry: See Registry
Protocol title: Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Registry: ClinicalTrials.gov
Registry #: NCT01309243
Link to registry: See Registry
Protocol title: A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Registry: ClinicalTrials.gov
Registry #: NCT01457768
Link to registry: See Registry
Protocol title: Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
Registry: ClinicalTrials.gov
Registry #: NCT01780506
Link to registry: See Registry
Protocol title: Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
Registry: ClinicalTrials.gov
Registry #: NCT01797445
Link to registry: See Registry
Protocol title: Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants
Registry: ClinicalTrials.gov
Registry #: NCT01815736
Link to registry: See Registry
Protocol title: A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults
Registry: ClinicalTrials.gov
Registry #: NCT01783678
Link to registry: See Registry
Protocol title: A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)
Registry: ClinicalTrials.gov
Registry #: NCT01632345
Link to registry: See Registry
Protocol title: Gilead Sustained Virologic Response (SVR) Registry
Registry: ClinicalTrials.gov
Registry #: NCT01457755
Link to registry: See Registry
Protocol title: Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)
Registry: ClinicalTrials.gov
Registry #: NCT02422797
Link to registry: See Registry
Protocol title: Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial
Registry: ClinicalTrials.gov
Registry #: NCT01177059
Link to registry: See Registry
Protocol title: Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed
Registry: ClinicalTrials.gov
Registry #: NCT02603120
Link to registry: See Registry
Protocol title: Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults
Registry: ClinicalTrials.gov
Registry #: NCT02603107
Link to registry: See Registry
Protocol title: Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
Registry: ClinicalTrials.gov
Registry #: NCT03239223
Link to registry: See Registry
Protocol title: Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia
Registry: ClinicalTrials.gov
Registry #: NCT02833844
Link to registry: See Registry
Protocol title: Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly
Registry: ClinicalTrials.gov
Registry #: NCT04139915
Link to registry: See Registry
Protocol title: A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Registry: ClinicalTrials.gov
Registry #: NCT03034915
Link to registry: See Registry
Protocol title: Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults
Registry: ClinicalTrials.gov
Registry #: NCT03299049
Link to registry: See Registry
Protocol title: Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients (SMART-C)
Registry: ClinicalTrials.gov
Registry #: NCT03117569
Link to registry: See Registry
Protocol title: A Study Assessing the Efficacy and Safety of CBP-201
Registry: ClinicalTrials.gov
Registry #: NCT04444752
Link to registry: See Registry
Protocol title: A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed (SOLAR)
Registry: ClinicalTrials.gov
Registry #: NCT04542070
Link to registry: See Registry
